Also trades as: BXRX (NASDAQ) · $vol 0M
BXRXQ OTC
Baudax Bio, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -90.0%
1Y: -90.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$28M
+43.6% ▲
Capital Expenditures
$20K
+90.1% ▲
5Y CAGR: -56.5%
Free Cash Flow
-$28M
+43.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$11M
+26.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$74M | -$33M | -$76M | -$20M | -$59M |
| Depreciation & Amort. | $396K | $480K | $3M | $3M | $2M |
| Stock-Based Comp. | $5M | $5M | $9M | $5M | $1M |
| Change in Working Capital | $447K | -$9M | $633K | -$3M | $62K |
| Other Non-Cash Items | $8M | -$15M | $20M | -$34M | $27M |
| Operating Cash Flow | -$60M | -$50M | -$44M | -$49M | -$28M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | -$1M | -$639K | -$203K | -$20K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$20M | $0 |
| Investment Sales | $0 | $0 | $0 | $20M | $0 |
| Other Investing | -$82K | -$165K | $0 | $0 | $0 |
| Investing Cash Flow | -$3M | -$1M | -$639K | -$194K | -$20K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $10M | $0 | -$2M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $63M | $69M | $2M | $4M | -$974K |
| Financing Cash Flow | $63M | $69M | $57M | $35M | $17M |
| Net Change in Cash | $0 | $18M | $13M | -$14M | -$11M |
| Cash End of Period | $0 | $18M | $30M | $16M | $5M |
| Free Cash Flow | -$63M | -$52M | -$45M | -$49M | -$28M |